Haemophilus influenzae type b (Hib) Vaccine Booster Dose (September 2009)

Why This Topic Matters

Immunization coding can change when vaccine recommendations, product availability, or administration guidance changes. This article helps readers understand the coding context for Hib booster vaccination and the organizations involved in the recommendation process.

Article Sections

1. Coding Communication: Haemophilus influenzae type b (Hib) Vaccine Booster Dose

   Introduces the September 2009 coding communication and summarizes the immunization policy background. It also notes the organizations involved in the recommendation process and the vaccine-supply context.

2. Vaccine availability and booster-dose reinstatement

   Describes the supply situation and the reinstatement of routine booster dosing for children who completed the primary Hib series. The section also references the broader immunization schedule framework and the age group affected by the update.

3. CPT reporting guidance for Hib booster vaccination

   Presents the CPT coding context for reporting the Hib booster vaccine and the associated administration service. It discusses the relevant vaccine product, administration coding framework, and age-based reporting considerations.

4. Reimbursement note

   Provides a general reminder about payer-specific reimbursement policies and the relationship between code inclusion and coverage. This section is administrative in nature and does not address clinical care.